News Releases Media Relations Contact Scott Shadiow Phone: +1.408-385-7563media@shockwavemedical.com Year None201920182017 11.14.2019 Shockwave Announces Pricing of Public Offering of Common Stock 11.12.2019 Shockwave Announces Proposed Public Offering of Common Stock 11.08.2019 Shockwave Medical to Participate in the 13th Annual Canaccord Genuity Medical Technologies & Diagnostics Forum 11.07.2019 Shockwave Medical Reports Third Quarter 2019 Financial Results 11.07.2019 Shockwave Initiates Study of Coronary Intravascular Lithotripsy in Japan 11.04.2019 Shockwave Announces Commercial Availability of Below-the-Knee IVL Catheter 10.17.2019 Shockwave Medical to Report Third Quarter 2019 Financial Results on November 7, 2019 09.25.2019 Shockwave Study Demonstrates Strong Safety and Procedural Success of Coronary IVL in Europe 09.03.2019 Shockwave Receives FDA Breakthrough Device Designation for the Coronary IVL System 08.21.2019 Shockwave Medical to Participate in Upcoming Investor Conferences 08.05.2019 Shockwave Medical Reports Second Quarter 2019 Financial Results 07.23.2019 Shockwave Medical to Report Second Quarter 2019 Financial Results on August 5, 2019 07.23.2019 Shockwave Medical to Participate in the 39th Annual Canaccord Genuity Global Growth Conference 06.10.2019 Shockwave Appoints Hajime Tada as General Counsel 05.15.2019 Shockwave Appoints Keith D. Dawkins M.D. as Chief Medical Officer 05.08.2019 Shockwave Medical Reports First Quarter 2019 Financial Results 05.01.2019 Shockwave Medical to Present at the Bank of America Merrill Lynch 2019 Health Care Conference 04.24.2019 Shockwave Medical to Report First Quarter 2019 Financial Results on May 8, 2019 04.03.2019 Shockwave Completes Enrollment of Disrupt CAD II Study 03.11.2019 ShockWave Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 20 of 24